Blood Serum Or Blood Plasma Standard Or Control Patents (Class 436/16)
  • Patent number: 4572899
    Abstract: An aqueous solution for suspending and storing cells, especially erythrocytes, and containing sodium chloride, glucose or fructose, adenine, and a sugar alcohol, the sugar alcohol being sorbitol or xylitol is employed to further improve the storage time and hence the survival rate of the cells and even reduce the hemolysis rate of erythrocytes in packed red blood cells.
    Type: Grant
    Filed: July 6, 1983
    Date of Patent: February 25, 1986
    Assignee: Biotest-Serum-Institut GmbH
    Inventors: Wolfram H. Walker, Karlheinz Ganshirt
  • Patent number: 4567748
    Abstract: A tonometer having vessels for producing and maintaining multi-levels of tonometerd aqueous buffered solutions and whole blood available for use in the quality controlling of a blood-gas analyzer. A water bath maintains all vessels at a predetermined temperature and gas mixtures are supplied at a very low rate thereby permitting continuous operation of the tonometer.
    Type: Grant
    Filed: July 19, 1984
    Date of Patent: February 4, 1986
    Inventors: Carl S. Klass, Ernest F. Geiger
  • Patent number: 4521518
    Abstract: An isotonic multipurpose blood diluent, and a method for use of this diluent with a weak lysing reagent system which is especially suitable for routine enumeration of traditional hemogram values, and also the determination of lymphoid-myeloid populations of leukocytes, particularly in automatic particle counting systems.This blood diluent is capable of affording accurate, reproducible test results. It is an osmotically balanced aqueous solution of preselected pH containing Procaine hydrochloride for maintaining erythrocyte morphology during operation, N-(2-acetamido)iminodiacetic acid (ADA) as a blood cell stabilizing agent, and bacteriostatic agents including sodium 1-hydroxypyridine-2-thione, and dimethylolurea which, together with the ADA, allow preferential determination of myeloid-lymphoid leukocytes, and other hematological values.The lysing agent is a mixture of an aqueous solution of at least one quaternary ammonium salt having surface active properties, and an alkali metal cyanide.
    Type: Grant
    Filed: July 6, 1982
    Date of Patent: June 4, 1985
    Assignee: Coulter Electronics, Inc.
    Inventors: James H. Carter, Stephen L. Ledis, Harold R. Crews
  • Patent number: 4495278
    Abstract: Viruses, particularly hepatitis viruses, in blood clotting enzyme compositions are inactivated with little enzyme activity loss by heating the compositions in the dry state. The novel products which result are therapeutically and diagnostically useful.
    Type: Grant
    Filed: April 27, 1981
    Date of Patent: January 22, 1985
    Assignee: Baxter Travenol Laboratories, Inc.
    Inventor: William R. Thomas
  • Patent number: 4483926
    Abstract: This invention encompasses methods and reagents for inactivation of bacterial growth inhibitors present in blood, serum or plasma. It has been found that salicylates and closely related compounds will neutralize bacterial growth inhibitors present in the blood of many patients. The addition of salicylate to conventional growth medium also provides a reagent for monitoring the antibiotic levels in blood by enabling measurement of the effect of the antibiotic against a standard test organism without interference from the bacterial growth inhibitor present in sera.
    Type: Grant
    Filed: May 3, 1982
    Date of Patent: November 20, 1984
    Assignee: Abbott Laboratories
    Inventors: George M. Fukui, Herbert J. Spencer, Laurens R. Williams, II
  • Patent number: 4480030
    Abstract: A process for quantitatively assaying factor Xa from a medium by reacting the medium with tripeptide derivatives having the formula ##STR1## wherein R.sup.5 is a chromogenic substituted amino group capable of being split off by enzymatic hydrolysis to form a colored or fluorescent product H--R.sup.5. The quantity of split product H--R.sup.5 released by the enzymatic action on the tripeptide derivative is determined photometrically, spectrophotometrically, fluorescence-spectrophotometrically, or electrochemically. The quantity of released split product H--R.sup.5 per time unit is proportional to the quantity of enzyme present in the starting material.
    Type: Grant
    Filed: September 15, 1982
    Date of Patent: October 30, 1984
    Assignee: Pentapharm A.G.
    Inventor: Lars G. Svendsen
  • Patent number: 4480029
    Abstract: Biological indicators are used to evaluate the effectiveness of virus inactivation conducted on virus-contaminated, protein-containing compositions. The indicators comprise dry protein and a predetermined titer of infectious virus.
    Type: Grant
    Filed: April 27, 1981
    Date of Patent: October 30, 1984
    Assignee: Baxter Travenol Laboratories, Inc.
    Inventor: Gary H. Dolana
  • Patent number: 4469792
    Abstract: A reference fluid for the calibration and control of blood gas instruments is comprised of substantially pure stroma-free hemoglobin solution, a buffering agent, a source of bicarbonate ion and predetermined amounts of gases found in in vivo blood.
    Type: Grant
    Filed: August 5, 1981
    Date of Patent: September 4, 1984
    Assignee: Allied Corporation
    Inventors: Richard S. Simmonds, Wells P. Owen
  • Patent number: 4465774
    Abstract: A control material for use in the determination of glycosylated and total hemoglobin, and a method of preparing the same, are disclosed. The control is prepared by the steps of hemolyzing red blood cells, preferably in the presence of a detergent, followed by removal of stroma and lipids from the hemoglobin with an organic solvent such as toluene in the presence of a polyhydroxy compound such as sucrose. A hemoglobin-rich fraction is separated from the resulting mixture and dialyzed against a solution of a polyhydroxy compound. The dialysate may be lyophilized to provide a stable, dry product suitable for reconstitution.
    Type: Grant
    Filed: July 16, 1981
    Date of Patent: August 14, 1984
    Assignee: Sherwood Medical Company
    Inventors: John J. Huang, Jung-Shou Chen, Louis M. Mezei
  • Patent number: 4458021
    Abstract: Disclosed are cell-free, stable, aqueous blood gas controls containing a proteinaceous foaming agent. The addition of foaming agent to the blood gas control permits generation of a gas impermeable foam within the head space of a sealed ampule in which the control is packaged. Upon agitation of the ampule prior to opening, the foam thus generated effectively isolates the control fluid from the ambient environment, thereby maintaining the concentration of gases dissolved within the fluid at their assigned values.
    Type: Grant
    Filed: May 3, 1982
    Date of Patent: July 3, 1984
    Assignee: American Hospital Supply Corporation
    Inventor: Kathryn D. Herring
  • Patent number: 4448888
    Abstract: Artificially constituted storage-stable hemoglobin compositions for use in the temperature correction of a cation exchange column chromatographic assay for hemoglobin A.sub.1 or A.sub.1c in a sample of human blood. The relative amounts of hemoglobin components in the composition conform approximately to the following formula:______________________________________ y = mx + b where y = weight percent A.sub.1c with respect to A.sub.1 x = weight percent A.sub.1 with respect to total hemoglobin m = -1.7 and b = 85 when x < 10, and m = -1.2 and b = 80 when x > 10. ______________________________________The compositions when analyzed in a cation exchange assay produce a result which varies with temperature in substantially the same manner as that from a true sample of human blood.
    Type: Grant
    Filed: August 24, 1982
    Date of Patent: May 15, 1984
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Dennis M. Bleile, Diane M. Allen, Steve K. Tanaka, Francis J. Matarrese, Jr.
  • Patent number: 4438202
    Abstract: A consistent, stable serum having good optical qualities and improved filterability suitable for control and calibration uses is disclosed as well as its method of preparation.
    Type: Grant
    Filed: November 30, 1981
    Date of Patent: March 20, 1984
    Assignee: Technicon Instruments Corporation
    Inventors: Philip V. Engler, Steven N. Buhl
  • Patent number: 4431560
    Abstract: An acidic solution of glycine and a fatty acid of 3 to 12 carbon atoms provides an improved solution for cleaning and storing blood dialyzers and other separation devices, particularly those intended for contact with blood after they have once been used.
    Type: Grant
    Filed: December 27, 1982
    Date of Patent: February 14, 1984
    Assignee: Baxter Travenol Laboratories, Inc.
    Inventors: William Lake, William J. Schnell
  • Patent number: 4412004
    Abstract: A method is disclosed of blood serum sample preparation for improved, more accurate and precise, electro-optical method for measuring erythrocyte volumes, individually and as an average.
    Type: Grant
    Filed: June 26, 1981
    Date of Patent: October 25, 1983
    Assignee: Technicon Instruments Corporation
    Inventors: Leonard Ornstein, Young R. Kim
  • Patent number: 4404285
    Abstract: A method for the removal of hormones from whole human serum which comprises: contacting, at a pressure higher than 1 psi the serum with a composite sheet, the composite sheet comprising a matrix of self-bonding fibers having interdispersed therein carbon particles, such that better than 90% of the carbon particles have an average diameter less than about 50 microns; and recovering a whole human serum having substantially undetectable amounts of hormones. The method is particularly useful for the removal of thyroid hormones.
    Type: Grant
    Filed: June 24, 1981
    Date of Patent: September 13, 1983
    Assignee: AMF Incorporated
    Inventor: Kenneth C. Hou
  • Patent number: 4403038
    Abstract: A method and system for measuring the oxygen carrying capacity of normal and abnormal hemoglobins and red cells under controlled pH, ionic strength, temperature and gas conditions is described. A blood sample and a physiologically balanced medium are placed in a cuvette and means are associated therewith for measuring the fractional saturation of the sample and the partial pressure of the oxygen (sometimes referred to as the oxygen tension) and provide output signals to an X-Y plotter for continuous recording. Preferably, means for maintaining the temperature of the medium and the blood sample is provided.
    Type: Grant
    Filed: September 3, 1981
    Date of Patent: September 6, 1983
    Inventors: Toshio Asakura, Horst K. Blume
  • Patent number: 4394452
    Abstract: Synthetic stool, adaptable to use as a control standard in the diagnostic detection of substances contained in stools and for demonstration purposes, said stool comprising a matrix of a member selected from the group consisting of oxygen-containing organic polymers which are difficultly soluble in water and oxygen-containing inorganic solids difficultly soluble in water, a non-bleeding coloring agent adherent to said matrix and simulating the color of a stool, and a liquid selected from the group consisting of water and lubricants.
    Type: Grant
    Filed: May 30, 1978
    Date of Patent: July 19, 1983
    Assignee: Rohm GmbH
    Inventors: Roland Hartl, Dieter Helm
  • Patent number: 4363633
    Abstract: A reference liquid for calibration or quality control of instruments which determine ionized calcium and pH. The reference liquid contains both a particular calcium ion activity and a pH-buffer and can therefore be used for calibration of both the calcium-sensitive electrode and the pH-electrode in the instruments. The pH-buffer is a nitrogen-containing organic sulphonic acid and the salt of this acid, the acid having a pK in the range of 6.6-7.6. The reference liquid has an ionic strength of 0.15-0.17, a buffer capacity .beta. in the range of 0.04-0.10 and is packed in glass ampoules.
    Type: Grant
    Filed: June 24, 1980
    Date of Patent: December 14, 1982
    Assignee: Radiometer A/S
    Inventor: Torben F. Christiansen